AccuBio AccuBio
Oncology
Products AccuBio Oncology AccuBio NMP22
AccuBio
Nuclear Matrix Protein 22 (NMP22)

NMP22 Rapid Test for the detection of the Nuclear Mitotic Apparatus Protein, a component of the nuclear matrix proteins, in urine of people at risk of or with symptoms of bladder cancer.

Visual read.

Professional use.

  • AccuBio
    Results in 15 minutes
  • AccuBio
    Urine
  • AccuBio
    CE mark
  • AccuBio
    24 months shelf-life
  • AccuBio
    2-30°C storage
AccuBio